| 1. |
Prasher, D.C., Eckenrode, V.K., Ward, W.W., Prendergast, F.G., and Cormier, M.J. (1992) Primary structure of the Aequorea victoria green-fluorescent protein. Gene
111, 229–233.
|
| |
| 2. |
Prasher, D.C. (1995) Using GFP to see the light. Trends Genet.
11, 320–323.
|
| |
| 3. |
Tsien, R.Y. (1998) The green fluorescent protein. Annu. Rev. Biochem.
67, 509–544.
|
| |
| 4. |
Zhang, J., Campbell, R.E., Ting, A.Y., and Tsien, R.Y. (2002) Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell. Biol.
3, 906–918.
|
| |
| 5. |
Ellenberg, J., Lippincott-Schwartz, J., Presley, J.F. (1999) Dual-colour imaging with GFP variants. Trends Cell Biol.
9, 52–56.
|
| |
| 6. |
Kallal, L., and Benovic, J.L. (2000) Using green fluorescent proteins to study G protein-coupled receptor localization and
trafficking. Trends Pharmacol. Sci.
21, 175–180.
|
| |
| 7. |
Milligan, G. (1999) Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent protein. Br. J. Pharmacol.
128, 501–510.
|
| |
| 8. |
Milligan, G. (2000) Insights into ligand pharmacology using receptor-G-protein fusion proteins. Trends Pharmacol. Sci.
21, 24–28.
|
| |
| 9. |
Azpiazu, I. and Gautam, N. (2004) A FRET based sensor indicates that receptor access to a G-protein is unrestricted in a living
mammalian cell. J. Biol. Chem.
279, 27,709–27,718.
|
| |
| 10. |
Overton, M.C. and Blumer, K.J. (2002) Use of fluorescence resonance energy transfer to analyze oligomerization of G protein-coupled
receptors expressed in yeast. Methods
27, 324–332.
|
| |
| 11. |
Gregan, B., Jürgensen, J., Papsdorf, G., et al. (2004) Ligand-dependent differences in the internalization of endothelin A
and endothelin B receptor heterodimers. J. Biol. Chem.
279, 27,679–27,687.
|
| |
| 12. |
Baird, G.S., Zacharias, D.A., and Tsien, R.Y. (2000) Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent
protein from coral. Proc. Natl. Acad. Sci. USA
97, 11,984–11,989.
|
| |
| 13. |
Daly, C.J. and McGrath, J.C. (2003) Fluorescent ligands, antibodies, and proteins for the study of receptors. Pharmacol. Ther.
100, 101–118.
|
| |
| 14. |
Oksche, A., Boese, G., Horstmeyer, A., et al. (2000) Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied
endothelin B (ETB) receptor. Mol. Pharmacol.
57, 1104–1113.
|
| |
| 15. |
Ferguson, S. S. (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and
signaling. Pharmacol. Rev.
53, 1–24.
|
| |
| 16. |
Ferguson, S.S., Zhang, J., Barak, L.S. and Caron, M.G. (1998) Molecular mechanisms of G protein-coupled receptor desensitization
and resensitization. Life Sci.
62, 1561–1565.
|
| |
| 17. |
Gurevich, V.V. and Gurevich, E.V. (2004) The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci.
25, 105–111.
|
| |
| 18. |
Ferguson, S.S., and Caron, M.G. (2004) Green fluorescent protein-tagged B-arrestin translocation as a measure of G protein-coupled
receptor activation. Methods Mol. Biol.
237, 121–126.
|
| |
| 19. |
Luttrell, L.M. and Lefkowitz, R.J. (2002) The role of ß-arrestins in the termination and transduction of G protein-coupled
receptor signals. J. Cell Sci.
115, 455–465.
|
| |
| 20. |
Mousavi, S. A., Malerod, L., Berg, T. and Kjeken, R. (2004) Clathrin-dependent endocytosis. Biochem. J.
377, 1–16.
|
| |
| 21. |
Schulz, R., Wehmeyer, A., and Schulz, K. (2002) Opioid receptor types selectively cointernalize with G protein-coupled receptor
kinases 2 and 3. J. Pharmacol. Exp. Ther.
300, 376–384.
|
| |
| 22. |
Barak, L.S., Wilbanks, A.M., and Caron, M.G. (2003) Constitutive desensitization: a new paradigm for G protein-coupled receptor
regulation. Assay Drug Dev. Technol.
1, 339–346.
|
| |
| 23. |
Janovick, J.A., Maya-Nunez, G., and Conn, P.M. (2002) Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH
receptor mutants by a specific protein-folding template: misrouted proteins as a novel diseaseetiology and therapeutic target.
J. Clin. Endocrinol. Metab.
87, 3255–3262
|
| |
| 24. |
Morello, J.P., Salahpour, A., Laperriere, A., et al. (2000) Pharmacological chaperones rescue cell-surface expression and
function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest.
105, 887–895.
|
| |
| 25. |
Noorwez, S.M., Kuksa, V., Imanishi, Y., et al. (2003) Pharmacological chaper-one-mediated in vivo folding and stabilization
of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem.
278, 14,442–14,450.
|
| |
| 26. |
Wüller, S., Wiesner, B., Löffler, A., et al. Pharmacochaperones posttranslationally enhance cell surface expression by increasing
conformational stability of wild-type and mutant vasopressin V2 receptors. J. Biol. Chem.
279, 47,254–47,263.
|
| |
| 27. |
Vilardaga, J.-P., Bünemann, M., Krasel, C., Castro, M. and Lohse, J.L. (2003) Measurement of the millisecond activation switch
of G protein-coupled receptors in living cells. Nature Biotech.
21, 807–812.
|
| |
| 28. |
Damke, H., Baba, T., Warnock, D.E., and Schmid, S.L. (1994) Induction of mutant dynamin specifically blocks endocytic coated
vesicle formation. J. Cell Biol.
127, 915–934.
|
| |
| 29. |
Gordon, G.W., Berry, G., Liang, X.H., Levine, B., and Herman, B. (1998) Quantitative fluorescence resonance energy transfer
measurements using fluorescence microscopy. Biophys. J.
74, 2702–2713.
|
| |
| 30. |
Petaja-Repo, U.E., Hogue, M., Bhalla, S., Laperriere, A., Morello, J.P. and Bouvier, M. (2002) Ligands act as pharmacological
chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J.
21, 1628–1637.
|
| |
| 31. |
Lenz, J.C., Reusch, H.P., Albrecht, N., Schultz, G., and Schaefer, M. (2002) Ca2+-controlled competitive diacylglycerol binding
of protein kinase C isoenzymes in living cells. J. Cell Biol.
159, 291–302.
|
| |